Abstract:Objective: To investigate the perfusion features of local recurrence in hepatocellular carcinoma (HCC) after radiofrequency ablation (RFA) with contrast-enhanced ultrasound (CEUS) and pathological correlation, as well as to compare with those of initial HCC.Methods: From 2010 to 2018, 42 patients with recurrent HCC after RFA were enrolled in this study. The initial HCC patients included 32 males and 10 females with an average age of 58.2 ± 8.1 years. The CEUS images for initial HCC lesions and local recurrence after RFA were compared. The perfusion features were analyzed, including enhancement time, process, boundary, morphology, washout time, washout degree, feeding vessels, and internal necrosis. H&E staining and CD133/EpCAM staining were performed with biopsy samples for the stemness study.Results: According to CEUS, 59.5% of initial HCC lesions had centripetal enhancement, and 61.9% of recurrent HCC lesions had homogeneous enhancement in the arterial phase (p < 0.001). A total of 73.8% of initial HCC lesions had well-defined margins at the peak, and 81.0% of recurrent HCC lesions had poorly defined margins (p < 0.001). A total of 78.6% of initial HCC lesions had regular morphology at the peak, and 83.3% of recurrent HCC lesions were irregular (p < 0.001). Feeding vessels were more frequently found in initial HCC lesion (71.4%) than in recurrent HCCs (38.1%, p = 0.002). In the late phase, 60% of initial HCCs had marked washout while 83.3% of recurrent HCC lesion had marked washout (p = 0.019). A total of 31.3% of the initial HCC lesions had internal necrosis areas while only 7.1% of recurrent HCC lesions had internal necrosis areas (p = 0.035). In tumors 3–5 cm in size, the washout time of recurrent HCCs was shorter than that of initial HCCs (50.3 ± 13.5 s vs. 75.6 ± 45.8 s, p = 0.013). Pathological staining showed that the tumor stem cell markers (CD133 and EpCAM) were both highly expressed in recurrent samples compared with initial tumor samples (CD133+: 19 vs. 5%, p = 0.002; EpCAM+:15 vs. 6%, p = 0.005).Conclusions: Recurrent HCC after RFA had more homogeneous enhancement with a poorly defined border, marked washout, and fewer less feeding vessels and inner necrosis areas compared to initial HCC. The stemness study also found upregulated stemness in recurrent HCC. These specific features might be related to the aggressive biological behavior of recurrent HCC.

Two dimensonal ultrasound and ultrasonic manifestation for tumor recurrence after liver transplantation

Clonal Origin of Hepatocellular Carcinoma and Recurrence after Liver Transplantation

Contrast-Enhanced Ultrasound to Monitor Early Recurrence of Primary Hepatocellular Carcinoma after Curative Treatment.

Role of Contrast Enhanced Ultrasound in Evaluating Hepatic Malignancies after Ablation

Contrast-Enhanced Ultrasound in Residual Tumor of Hepatocellular Carcinoma Following Transarterial Chemoembolization: is It Helpful for Tumor Response?

The study on recurrent hepatocelluar carcinoma by SonoVue-enhanced ultrasonography

Clinical application of contrast-enhanced ultrasonography for malignant hepatic lesions undetected on conventional ultrasound

Comparison of hemodynamics of primary and recurrent small hepatocellular carcinomas on contrast-enhanced ultrasound

The Perfusion Features of Recurrent Hepatocellular Carcinoma After Radiofrequency Ablation Using Contrast-Enhanced Ultrasound and Pathological Stemness Evaluation: Compared to Initial Tumors

The Contrast-Enhanced Ultrasonography Patterns and the Diagnostic Values of Local Treatment of Primary Hepatic Carcinama and Hepatic Metastasis

The clinical application of contrast enhanced ultrasonography in radiofrequency ablation therapy for residual and recurrent hepatic neoplasms

Comparative study on hemodynamics features of recurrent hepatocellular carcinoma between contrast-enhanced ultrasonography and contrast-enhanced MRI

Contrast-Enhanced Ultrasound Features of Histopathologically Proven Hepatocellular Carcinoma in the Non-cirrhotic Liver: A Multicenter Study

The Characteristics Observation of the Contrast-enhanced Ultrasound about the Lesions of Alpha-fetoprotein Negative Recurrent Hepatocellular Carcinoma

Comparison of contrast-enhanced ultrasonographic features between recurrent and primary hepatocellular carcinomas with different diameters

[Recurrence and Metastasis of Hepatocellular Carcinoma after Liver Transplantation: Single Center Experiences].

Evaluation Of Liver Metastases Using Contrast-Enhanced Ultrasound: Enhancement Patterns And Influencing Factors

Recurrence of hepatocellular carcinoma after liver transplantation: clinical patterns and hierarchy of salvage treatments

Dynamic Contrast-Enhanced Ultrasound in the Prediction of Advanced Hepatocellular Carcinoma Response to Systemic and Locoregional Therapies

Evaluation of Contrast-Enhanced Ultrasound for Diagnosis of Dysplastic Nodules with a Focus of Hepatocellular Carcinoma in Liver Cirrhosis Patients

The value of contrast-enhanced ultrasound quantitative parameters in the prognosis prediction of hepatocellular carcinoma after thermal ablation: a retrospective cohort study